Top section
Top section
International investors take most of the book for the first time as Zabłocki's investment firm says it expects to make no further sales
Despite rough market conditions and angst over rates, array of deals have been well taken
It is difficult to see issuance conditions growing much better in the foreseeable future
Data
More articles
More articles
More articles
-
Chaoju Eye Care Holdings is gauging investor appetite for a HK$1.81bn ($233m) listing on the Hong Kong Stock Exchange, becoming the latest healthcare related company to seek an IPO. -
I have used Covid-19 as an excuse to avoid some unwanted social occasions over the last year or so, but a friend of mind has taken his Covid isolation to a new level.
-
Chinese technology companies are flocking back to the US for IPOs after months of poor market conditions and the regulatory crackdown on the sector brought deal flow to a near halt. There is more on the way too, as issuers look to wrap up deals before the summer slowdown. Jonathan Breen reports.
-
Biopharmaceutical company HutchMed (China) pocketed HK$4.17bn ($537.1m) this week from its Hong Kong IPO.
-
Beijing Construction Engineering Group sold a tightly priced $600m bond by getting a rating for the first time, a move that made a ‘huge difference’ to the company’s fundraising.
-
The offshore renminbi (CNH) bond market saw a jump in action this week, with three issuers taking advantage of favourable issuing conditions to roll out deals. Addison Gong reports.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
